LungBlog

 Nearly 400 people came out to support the seventh annual Lung Cancer Awareness 5K run and walk.

Lung cancer is the number one killer of both men and women in the U.S. The proceeds will be donated to a research center in Syracuse.

The solution to a key mystery in smokers’ lung cancer risk may lie in reduced transcription activity of certain antioxidant and DNA repair genes, investigators reported here.

A study of lung cancer patients in the Indian River area will cost about $100,000, as state officials try to rule out whether tobacco exposure was the culprit

Your doctor may monitor your blood cell counts carefully during your cancer treatment. There’s a good reason you’re having your blood drawn so often — low blood cell counts put you at risk of serious complications.

Results published today in the Journal of Clinical Oncology(1) show that the AstraZeneca investigational once-daily oral anti-cancer drug vandetanib (ZACTIMA), in combination with docetaxel, improved progression free survival (PFS) in patients with advanced Non-Small Cell Lung Cancer (NSCLC).

That’s because Dave Schultz, 53, has cancer of the brain, the lungs and the colon.

Schultz, a Clinton High grad, has worked for 30 years for Darryl Blinkinsop, siding homes throughout Clinton.

“Nobody’s as good as Uncle Dave,” boasts his proud niece, Dawn Luett, of Goose Lake

Lung cancer is the second most common cancer in America and the leading cause of cancer death. This year, the American Cancer Society estimates 213,380 new cases will be diagnosed. Nearly 70 percent of people are over 65 at the time of diagnosis. About 160,390 men and women will die from the disease.

Eli Lilly and Company today announced that it has submitted an application with the European Medicines Agency (EMEA) for centralised review of ALIMTA(R) (pemetrexed for injection), in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer (NSCLC).

A pharmaceutical company is developing a highly sensitive test that could catch the deadly disease in its early stages.

Lung cancer kills more Americans than any other cancer. Doctors know that smokers and former smokers are at much greater risk than the rest of the population, yet there’s no safe way to screen them, and lung tumors are rarely discovered in early, more curable stages.